Synthetic control arms in clinical trials: Making it happen
Posted:
Can combining #AI tech & #RWD hold the key to overcoming challenges in #clinicaltrial design?
Join Sensyne Health on 24th February 2:00 p.m. GMT as experts discuss the application of #SyntheticControlArms – a new way of approaching clinical trials.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us